Stocks and Investing Stocks and Investing
Wed, February 23, 2022
Tue, February 22, 2022
Sun, February 20, 2022
Fri, February 18, 2022
Thu, February 17, 2022

Patrick Donnelly Maintained (TXG) at Strong Buy with Decreased Target to $150 on, Feb 17th, 2022


Published on 2024-10-27 19:44:12 - WOPRAI, Patrick Donnelly
  Print publication without navigation


Patrick Donnelly of Citigroup, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Decreased Target from $175 to $150 on, Feb 17th, 2022.

Patrick has made no other calls on TXG in the last 4 months.



There is 1 other peer that has a rating on TXG. Out of the 1 peers that are also analyzing TXG, 0 agree with Patrick's Rating of Hold.



This is the rating of the analyst that currently disagrees with Patrick


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $205 on, Thursday, November 4th, 2021